Skip to main content
logo
Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
1,505.00
+6.00 (0.40%)
At close: Mar 6, 2026

TYO:4570 Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
1,031969816794647602
Revenue Growth (YoY)
8.76%18.75%2.77%22.72%7.47%4.51%
Cost of Revenue
305335300268271256
Gross Profit
726634516526376346
Selling, General & Admin
293300282289310320
Research & Development
119119129179188267
Operating Expenses
418425406474498587
Operating Income
30820911052-122-241
Interest Expense
-2-1-1-1--
Interest & Investment Income
---1--
Earnings From Equity Investments
----203-152-90
Currency Exchange Gain (Loss)
1-38434
Other Non Operating Income (Expenses)
1057122817
EBT Excluding Unusual Items
317210124-135-243-310
Gain (Loss) on Sale of Investments
----130--
Asset Writedown
----14-7-
Other Unusual Items
----1--
Pretax Income
317210124-280-250-310
Income Tax Expense
-47-39-62988
Earnings From Continuing Operations
364249186-289-258-318
Net Income
364249186-289-258-318
Net Income to Common
364249186-289-258-318
Net Income Growth
21.74%33.87%----
Shares Outstanding (Basic)
999999
Shares Outstanding (Diluted)
999999
Shares Change (YoY)
-----5.95%
EPS (Basic)
39.0826.7419.97-31.03-27.70-34.14
EPS (Diluted)
39.0826.7419.97-31.03-27.70-34.14
EPS Growth
21.74%33.87%----
Free Cash Flow
-12411726-93-207
Free Cash Flow Per Share
-13.3112.562.79-9.99-22.23
Gross Margin
70.42%65.43%63.23%66.25%58.11%57.48%
Operating Margin
29.87%21.57%13.48%6.55%-18.86%-40.03%
Profit Margin
35.31%25.70%22.79%-36.40%-39.88%-52.82%
Free Cash Flow Margin
-12.80%14.34%3.28%-14.37%-34.38%
EBITDA
332.75224112---
EBITDA Margin
32.27%23.12%13.73%---
D&A For EBITDA
24.75152---
EBIT
30820911052-122-241
EBIT Margin
29.87%21.57%13.48%6.55%-18.86%-40.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.